Page 5,126«..1020..5,1255,1265,1275,128..5,1405,150..»

An Overview of Incontinence and Erectile Dysfunction for Prostate Cancer Survivors: 1 of 8 – Video

Posted: Published on June 18th, 2013

An Overview of Incontinence and Erectile Dysfunction for Prostate Cancer Survivors: 1 of 8 Part 1: Introduction. By Dr. Michael B Greenspan M.D., F.R.C.S. (c) Urology Hamilton General Hospital Assistant Professor, Department of Surgery (Urology) Mc... By: ProstateCancerCanada … Continue reading

Posted in Erectile Dysfunction | Comments Off on An Overview of Incontinence and Erectile Dysfunction for Prostate Cancer Survivors: 1 of 8 – Video

Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …

Posted: Published on June 18th, 2013

Sarasota, Florida (PRWEB) June 18, 2013 After almost 20 years of performing regenerative treatments in the field of non surgical orthopedics, Wellington Chen, M.D., will begin conducting clinical trials for many degenerative diseases using adipose-derived stem cell therapy in Sarasota, Florida. The independent review board of the International cell medicine society is responsible for overseeing these trials. Advanced Rejuvenation will treat patients suffering from chronic obstructive pulmonary disease (COPD) and osteoarthritis following the IRB-approved protocols. Advanced Rejuvenation will be using adult autologous stem cells, harvested from the patients own adipose (fat) tissue or bone marrow if fat is not available. Because patients are receiving their own cells, there is no risk of rejection. As of 2007, over 9,000 studies have shown the safety using these cell lines. Autologous stem cell therapy are your bodies repair men. They are circulated throughout your body and as soon as there is a need for them, chemical messages trigger them to migrate to the area and do their magic. They are both immune modulating and also regenerative which makes them a great therapeutic agent for osteoarthritis and COPD. Numerous studies have shown them to have the capacity to grow new cartilage, muscle, ligaments, glands … Continue reading

Posted in Cell Therapy | Comments Off on Wellington Chen, M.D. of Advanced Rejuvenation Introduces Stem Cell Therapy For OsteoArthritis & COPD in Sarasota …

A Path to Lower-Risk Painkillers

Posted: Published on June 18th, 2013

You are here: All Articles A Path to Lower-Risk Painkillers New findings provide a vital step towards exploring pain medications that may lower risks of prescription drug abuse and side effects of painkillers, according to a release from the University of Michigan Health System. The study is published in the journal Proceedings of the National Academy of Sciences. A release from the university notes that drugs such as hydrocodone, the main ingredient of Vicodin, and oxycodone (Oxycontin) are often the best options for the treatment of moderate to severe pain for patients facing medical conditions ranging from a wisdom tooth extraction to cancer. The release notes that these drugs bind to specific molecules called opioid receptors on nerve cells in the brain and spinal cord to prevent the feeling of pain. Yet the body's tendency to develop tolerance to these medications can require patients to take higher doses, which increases risks of harmful side effects and dependency. Co-author John Traynor, Ph.D is quoted as saying, "We have for the first time discovered compounds that bind to an alternative site on the nerve opioid receptors and that have significant potential to enhance the drug's positive impact without increasing negative side effects. … Continue reading

Posted in Drug Side Effects | Comments Off on A Path to Lower-Risk Painkillers

DrugRisk Update: FDA Meets to Discuss Study for Byetta Cancer Risk

Posted: Published on June 18th, 2013

Los Angeles, CA (PRWEB) June 18, 2013 The diabetes drug safety center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. The FDA met with drug makers last week to decide additional safety studies of the drug after reports linking it to pancreatic cancer*. The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs by providing the latest warnings, recalls, studies and legal news. Visitors can see if others are experiencing similar side effects and decide if they need legal advice. Byetta is a twice-daily injectable medication released in 2005 to help those with type-2 diabetes control blood sugar. Last year the drug had sales of over $300 million for manufacturer Bristol-Myers Squibb**. The resource center added a 2011 study from the University of California at Los Angeles, indicating Byetta could increase the risk of pancreatic cancer by 290% and thyroid cancer by 473%***. The Journal for the American Medical Association also recently warned that drugs like Byetta can double the risk of pancreatitis, a major risk factor for pancreatic cancer****. Now, DrugRisk has learned that the FDA met last week with diabetes drug manufacturers to discuss how to approach new studies … Continue reading

Posted in Drug Side Effects | Comments Off on DrugRisk Update: FDA Meets to Discuss Study for Byetta Cancer Risk

Your Voice 17 June

Posted: Published on June 18th, 2013

Johns words just tired and lazy rhetoric In response to John Letfords column on Dundees drug problem, how wonderful it must be for him to see the world in simple black and white. John might want to consider that the work-shy hangers-on and self-inflicted people he claims to have no sympathy for are still someones son or daughter. Drug or alcohol dependency is a complex issue and the reasons behind why people become addicted are most often linked to wider, deeper issues. John calls for a drugs tsar with dedicated expertise, but at the same time tells us we dont need so-called experts to explain the difficulties of addiction. I would like to know what he thinks the tsar would be doing because John tells us he has no respect for those who defend addicts. Would the tsars approach therefore be one which judges, persecutes and punishes people? John offers no real answers, just more tired, lazy rhetoric. Jock Tamsons Bairn. Im a big fan of John Letford, but I couldnt agree with his hard line argument on drug addiction. If people dont agree with current efforts then what do the hard-liners suggest? See the original post: Your Voice 17 … Continue reading

Posted in Drug Dependency | Comments Off on Your Voice 17 June

Clonazepam Addiction Treatment and Clonozepam Drug Rehab Announced by Recovery Associates

Posted: Published on June 18th, 2013

West Palm Beach, FL (PRWEB) June 18, 2013 Recovery Associates, through its multiple therapeutic tracks, is pleased to announce that its expanding treatment programs focused on Clonazepam addiction, helping men and women stop abusing this powerful drug. Clonazepam, which also goes by the drug name klonopin, is a medication used to help control seizures. It also can be prescribed to alleviate panic attacks. This drug works by decreasing electrical activity in the brain. Yet it also can become a drug of choice and addictive. Signs of clonazepam abuse include tolerance to the drug, onset of withdrawal symptoms after not using clonazepam for a period of time, having difficulty concentrating and/or remembering facts or events, and consuming it uncontrollably. Using clonazepam in an addictive, obsessive, out-of-control way can lead an individual to suffer severe consequences. Drug rehab options are available, and Recovery Associates has developed strong substance abuse treatment programs for people addicted to drugs and alcohol. Recovery Associates is a drug and alcohol treatment center that provides a variety of programs and services for men, women and teens struggling with chemical dependency issues. At the core of their philosophy is the belief that addiction is a treatable illness. Their addiction … Continue reading

Posted in Drug Dependency | Comments Off on Clonazepam Addiction Treatment and Clonozepam Drug Rehab Announced by Recovery Associates

Label Expansion for Astellas Drug – Analyst Blog

Posted: Published on June 18th, 2013

Astellas Pharma Inc. ( ALPMY ) recently announced the approval of Prograf in Japan for an additional indication. Prograf is now approved for interstitial pneumonia associated with polymyositis/dermatomyositis.It was granted orphan drug status by the Ministry of Health, Labor and Welfare (MHLW). Prograf is already available in Japan to prevent organ rejection in transplant recipients, the prevention of rejection in bone marrow transplant recipients, the treatment of myasthenia gravis, the treatment of rheumatoid arthritis in patients who respond insufficiently to existing therapies, the treatment of moderate/severe refractory (steroid resistance and steroid dependency) ulcerative colitis and also for the treatment of lupus nephritis. Prograf generated global sales of 161.7 billion yen in 2012, including 49.4 billion yen from Japan, 31.4 billion yen from the Americas, 57.5 billion yen from Europe and 18.9 billion yen from Asia. Prograf is also available in the US to prevent organ rejection in patients who have had a kidney, liver or heart transplant. US patents for Prograf expired in Apr 2008 and Prograf patents in major European countries expired in Jun 2009. Currently, Prograf faces generic competition in the US. Generic versions of Prograf were launched by companies like Mylan Inc ( MYL ), Dr. Reddy's … Continue reading

Posted in Drug Dependency | Comments Off on Label Expansion for Astellas Drug – Analyst Blog

If coffee perks you up, you need to STOP drinking it

Posted: Published on June 18th, 2013

Scientists differ on the effects of caffeine, but a new study reveals that... Coffee-drinkers aren't more alert than their caffeine-free counterparts What's more, regular consumption of tea and coffee leads to dependency By Kate Wighton PUBLISHED: 16:37 EST, 17 June 2013 | UPDATED: 02:19 EST, 18 June 2013 874 shares 220 View comments Every morning, millions of people perform an essential daily ritual - having their first cup of tea or coffee. It concentrates the mind and acts as a pick-me-up. Or does it? The latest research suggests that familiar buzz doesn't so much as give us a lift, but fights the caffeine withdrawal symptoms - fatigue, mental fogginess and a dull headache - that have kicked in since our last cup. Indeed, experts suggest that this morning ritual is actually a sign of mass drug dependency. Shaking the habitual: Many can't start the day without a cup of tea or coffee, but it's been proven that caffeine doesn't actually jump start your brain Read this article: If coffee perks you up, you need to STOP drinking it … Continue reading

Posted in Drug Dependency | Comments Off on If coffee perks you up, you need to STOP drinking it

Label Expansion for Astellas Drug

Posted: Published on June 18th, 2013

Astellas Pharma Inc. (ALPMY) recently announced the approval of Prograf in Japan for an additional indication. Prograf is now approved for interstitial pneumonia associated with polymyositis/dermatomyositis.It was granted orphan drug status by the Ministry of Health, Labor and Welfare (:MHLW). Prograf is already available in Japan to prevent organ rejection in transplant recipients, the prevention of rejection in bone marrow transplant recipients, the treatment of myasthenia gravis, the treatment of rheumatoid arthritis in patients who respond insufficiently to existing therapies, the treatment of moderate/severe refractory (steroid resistance and steroid dependency) ulcerative colitis and also for the treatment of lupus nephritis. Prograf generated global sales of 161.7 billion yen in 2012, including 49.4 billion yen from Japan, 31.4 billion yen from the Americas, 57.5 billion yen from Europe and 18.9 billion yen from Asia. Prograf is also available in the US to prevent organ rejection in patients who have had a kidney, liver or heart transplant. US patents for Prograf expired in Apr 2008 and Prograf patents in major European countries expired in Jun 2009. Currently, Prograf faces generic competition in the US. Generic versions of Prograf were launched by companies like Mylan Inc (MYL), Dr. Reddy's Laboratories Ltd. (RDY) and … Continue reading

Posted in Drug Dependency | Comments Off on Label Expansion for Astellas Drug

The buzz from coffee is a sign of drug dependency says Bristol professor

Posted: Published on June 18th, 2013

The morning pick-me-up coffee drinkers crave is actually a sign of drug dependency, according to a Bristol professor. Research from Bristol University shows that the buzz gained from a cup of coffee is actually a sign of it fighting caffeine withdrawal symptoms that have kicked in since the last cup. Professor of biological psychology and caffeine expert, Peter Rogers, told the Mail that people who regularly drink caffeine become dependent on it and struggle to function without it. They just don't function normally without the drug on board, he said. Azuza Terms: Valid until Friday 6th September Contact: 0117 9349903 Valid until: Friday, September 06 2013 If it's your first tea or coffee of the day, it gets you back to normal, but beyond that you don't get much more of a kick. Prof Rogers has studied coffee and its effects for more than 20 years and as a result of his findings he and his colleagues have given up caffeine themselves. More: The buzz from coffee is a sign of drug dependency says Bristol professor … Continue reading

Posted in Drug Dependency | Comments Off on The buzz from coffee is a sign of drug dependency says Bristol professor

Page 5,126«..1020..5,1255,1265,1275,128..5,1405,150..»